Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.66% |
| 2 | Consumer Discretionary | 8.08% |
| 3 | Energy | 7.71% |
| 4 | Technology | 6.85% |
| 5 | Industrials | 5.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
CALL
SBA Communications
SBAC
$19.6B
| $877K | ﹤0.01% |
10,900
-1,600
| -13% | -$121K |
|
|
AMED
3127
CALL
DELISTED
Amedisys
AMED
| $876K | ﹤0.01% |
50,900
+5,900
| +13% | +$87.5K |
|
3128
InterDigital
IDCC
$8.87B
| $876K | ﹤0.01% |
23,475
-35,468
| -60% | -$1.34M |
|
|
VPHM
3129
PUT
DELISTED
VIROPHARMA INC
VPHM
| $876K | ﹤0.01% |
22,300
+7,600
| +52% | +$248K |
|
|
RPRX
3130
CALL
DELISTED
Repros Therapeutics Inc.
RPRX
| $874K | ﹤0.01% |
32,600
-5,600
| -15% | -$120K |
|
3131
Philips
PHG
$26.7B
| $872K | ﹤0.01% |
39,001
+23,032
| +144% | +$503K |
|
|
KBAL
3132
DELISTED
Kimball International
KBAL
| $872K | ﹤0.01% |
100,656
-89,487
| -47% | -$757K |
|
|
KWK
3133
DELISTED
QUICKSILVER RESOURCES INC
KWK
| $870K | ﹤0.01% |
441,617
-223,892
| -34% | -$380K |
|
3134
Banco Santander Chile
BSAC
$16.3B
| $869K | ﹤0.01% |
33,078
-52,691
| -61% | -$1.26M |
|
3135
AZZ Inc
AZZ
$4.55B
| $867K | ﹤0.01% |
20,715
-8,271
| -29% | -$319K |
|
3136
PUT
Interactive Brokers
IBKR
$41.7B
| $865K | ﹤0.01% |
184,400
-7,600
| -4% | -$32.6K |
|
3137
PUT
Vulcan Materials
VMC
$36.5B
| $865K | ﹤0.01% |
16,700
+3,000
| +22% | +$148K |
|
3138
Vertex Pharmaceuticals
VRTX
$128B
| $864K | ﹤0.01% |
+11,387
| New | +$906K |
|
|
BKW
3139
CALL
DELISTED
BURGER KING WORLDWIDE
BKW
| $863K | ﹤0.01% |
44,200
-14,000
| -24% | -$276K |
|
3140
NorthWestern Energy
NWE
$4.42B
| $862K | ﹤0.01% |
19,195
-25,791
| -57% | -$1.08M |
|
|
GTAT
3141
CALL
DELISTED
GT ADVANCED TECHNOLOGIES INC COM STK (DE)
GTAT
| $861K | ﹤0.01% |
101,200
+84,800
| +517% | +$506K |
|
3142
Chefs' Warehouse
CHEF
$4.45B
| $858K | ﹤0.01% |
+37,115
| New | +$797K |
|
|
SAFE
3143
Safehold
SAFE
$1.08B
| $858K | ﹤0.01% |
14,644
-3,669
| -20% | -$206K |
|
3144
CALL
Acacia Research
ACTG
$448M
| $856K | ﹤0.01% |
37,100
-19,700
| -35% | -$451K |
|
3145
CALL
Ares Capital
ARCC
$14.3B
| $856K | ﹤0.01% |
49,500
+39,000
| +371% | +$683K |
|
3146
PUT
Acuity Brands
AYI
$10.7B
| $856K | ﹤0.01% |
9,300
+2,900
| +45% | +$253K |
|
|
AMWD
3147
DELISTED
American Woodmark
AMWD
| $855K | ﹤0.01% |
24,699
-13,660
| -36% | -$489K |
|
3148
Digital Realty Trust
DLR
$74.1B
| $855K | ﹤0.01% |
16,106
-827,498
| -98% | -$47.1M |
|
3149
CALL
IAMGOLD
IAG
$10.4B
| $855K | ﹤0.01% |
180,000
+36,200
| +25% | +$190K |
|
3150
Iridium Communications
IRDM
$5.32B
| $855K | ﹤0.01% |
124,203
+81,988
| +194% | +$614K |
|
Similar funds
Citadel Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Citadel Advisors held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Citadel Advisors's Q3 2013 filing shows 735 new, 2,740 increased, 3,074 reduced and 505 closed positions. Its largest new stake was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M. The largest sale was Pfizer, an estimated $245M.
By sector, the portfolio is most concentrated in Financials at 9.7% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Energy.
- Citadel Advisors's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Citadel Advisors added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Citadel Advisors's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Citadel Advisors fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Citadel Advisors's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Citadel Advisors opened 735 new positions and closed 505 in Q3 2013.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.